CELLERIX
Cellerix, S.A., a biotechnology company, engages in the development and production of medicines based on the use of stem cells of adult origin. The company offers products for the treatment of gastroenterology, dermatology, and immune-based diseases. Its products include Cx401, which is used for the treatment of complex perianal fistulas; and Cx501, a cell therapy product to be applied in the treatment of Epidermolysis Bullosa. Cellerix, S.A. was founded in 2004 and is based in Tres Cantos, Spain.
CELLERIX
Social Links:
Industry:
Biotechnology Medical Pharmaceutical
Founded:
2004-01-01
Address:
Madrid, Madrid, Spain
Country:
Spain
Website Url:
http://www.cellerix.com
Total Employee:
51+
Status:
Closed
Contact:
+34 91 804 92 64
Total Funding:
115.35 M USD
Technology used in webpage:
Apache GlobalSign GeoTrust SSL RapidSSL Debian Dynatrace Tierpoint Goscomb
Investors List
Life Sciences Partners
Life Sciences Partners investment in Series C - Cellerix
Ysios Capital
Ysios Capital investment in Series C - Cellerix
Roche Venture Fund
Roche Venture Fund investment in Series C - Cellerix
Ventech
Ventech investment in Series C - Cellerix
Grupo Genetrix
Grupo Genetrix investment in Series C - Cellerix
Novartis Venture Fund
Novartis Venture Fund investment in Series C - Cellerix
Biopartners Capital
Biopartners Capital investment in Series B - Cellerix
Roche Venture Fund
Roche Venture Fund investment in Series B - Cellerix
Novartis Venture Fund
Novartis Venture Fund investment in Series B - Cellerix
Ysios Capital
Ysios Capital investment in Series B - Cellerix
